Both in Pharmaceuticals
Braveheart Bio vs Zenas BioPharma
Over the past year BRVE returned −19.4% and ZBIO returned −9.3%; their daily moves had a correlation of 0.10.
BRVE −19.4% ZBIO −9.3%Growth of $1, one year, split-adjusted
| Metric | BRVE | ZBIO |
|---|---|---|
| Price | $21.48 | $28.23 |
| Market cap | $1.93B | $1.84B |
| Today | +2.09% | +0.53% |
| 1 month | +0.1% | −4.7% |
| 6 months | — | +52.7% |
| Year to date | — | −22.3% |
| 1 year | — | +8.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,839.9× |
| Net cash | — | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 54.3% |
| Short % of float | 7.3% | 38.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).